Skip to content
Interagency Autism Coordinating Committee (IACC)
Autism Research Database
Office of Autism Research Coordination (OARC)
 
Project Element Element Description

Project Title

Project Title

Treatment of autism spectrum disorders with a glutamate antagonist

Principal Investigator

Principal Investigator

Swedo, Susan

Description

Description

The study is a 12-week, placebo-controlled investigation of the safety and efficacy of riluzole for the treatment of obsessive-compulsive symptoms among 30 children and adolescents (ages 7 to 17 years) with autism spectrum disorder (ASD) and obsessive-compulsive disorder (OCD).

Funder

Funder

National Institutes of Health

Fiscal Year Funding

Fiscal Year Funding

465840

Current Award Period

Current Award Period

na

Strategic Plan Question

Strategic Plan Question

Question 4: Which Treatments And Interventions Will Help?

Strategic Plan Objective

Strategic Plan Objective

Green dot: Objective has greater than or equal to the recommended funding. 4.7 Complete two multi-site randomized controlled trials of comprehensive early intervention that address core symptoms, family functioning and community involvement by 2013. IACC Recommended Budget: $16,700,000 over 5 years.

Project Link

Project Link

No link available.

Institution

Institution

National Institutes of Health

State/Country

State/Country

Maryland

Project Number

Project Number

Z01MH002913-01

Federal or Private?

Federal or Private?

Federal

Received ARRA Funding?

Received ARRA Funding?

No

History/Related Projects

History/Related Projects

Treatment of autism spectrum disorders with a glutamate antagonist | 203517 | 2009 | 1ZIAMH002913-02

 
Back to Top